These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23947621)

  • 1. Rho-kinase inhibitor prevents bleomycin-induced injury in neonatal rats independent of effects on lung inflammation.
    Lee AH; Dhaliwal R; Kantores C; Ivanovska J; Gosal K; McNamara PJ; Letarte M; Jankov RP
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):61-73. PubMed ID: 23947621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic hypercapnia prevents bleomycin-induced pulmonary hypertension in neonatal rats by limiting macrophage-derived tumor necrosis factor-α.
    Sewing AC; Kantores C; Ivanovska J; Lee AH; Masood A; Jain A; McNamara PJ; Tanswell AK; Jankov RP
    Am J Physiol Lung Cell Mol Physiol; 2012 Jul; 303(1):L75-87. PubMed ID: 22582114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of rho-kinase inhibition on pulmonary hypertension, lung growth, and structure in neonatal rats chronically exposed to hypoxia.
    Ziino AJ; Ivanovska J; Belcastro R; Kantores C; Xu EZ; Lau M; McNamara PJ; Tanswell AK; Jankov RP
    Pediatr Res; 2010 Feb; 67(2):177-82. PubMed ID: 19858775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.
    Xu EZ; Kantores C; Ivanovska J; Engelberts D; Kavanagh BP; McNamara PJ; Jankov RP
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1854-64. PubMed ID: 20889845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute vasodilator effects of Rho-kinase inhibitors in neonatal rats with pulmonary hypertension unresponsive to nitric oxide.
    McNamara PJ; Murthy P; Kantores C; Teixeira L; Engelberts D; van Vliet T; Kavanagh BP; Jankov RP
    Am J Physiol Lung Cell Mol Physiol; 2008 Feb; 294(2):L205-13. PubMed ID: 18032699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1-Rho kinase interactions impair lung structure and cause pulmonary hypertension after bleomycin exposure in neonatal rat pups.
    Gien J; Tseng N; Seedorf G; Kuhn K; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1090-L1100. PubMed ID: 27760762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of lung ischemia-reperfusion injury by rho-associated kinase inhibition in a rat model of lung transplantation.
    Kohno M; Watanabe M; Goto T; Kamiyama I; Ohtsuka T; Tasaka S; Sawafuji M
    Ann Thorac Cardiovasc Surg; 2014; 20(5):359-64. PubMed ID: 24088927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukotriene B4 mediates macrophage influx and pulmonary hypertension in bleomycin-induced chronic neonatal lung injury.
    Ee MT; Kantores C; Ivanovska J; Wong MJ; Jain A; Jankov RP
    Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L292-302. PubMed ID: 27317685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant CCN1 prevents hyperoxia-induced lung injury in neonatal rats.
    Vaidya R; Zambrano R; Hummler JK; Luo S; Duncan MR; Young K; Lau LF; Wu S
    Pediatr Res; 2017 Nov; 82(5):863-871. PubMed ID: 28700567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled nitric oxide improves lung structure and pulmonary hypertension in a model of bleomycin-induced bronchopulmonary dysplasia in neonatal rats.
    Tourneux P; Markham N; Seedorf G; Balasubramaniam V; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2009 Dec; 297(6):L1103-11. PubMed ID: 19837849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginase inhibition prevents bleomycin-induced pulmonary hypertension, vascular remodeling, and collagen deposition in neonatal rat lungs.
    Grasemann H; Dhaliwal R; Ivanovska J; Kantores C; McNamara PJ; Scott JA; Belik J; Jankov RP
    Am J Physiol Lung Cell Mol Physiol; 2015 Mar; 308(6):L503-10. PubMed ID: 25595650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho-kinase inhibitor Y-27632 attenuates pulmonary hypertension in hyperoxia-exposed newborn rats.
    Chou HC; Huang LT; Yeh TF; Chen CM
    Acta Pharmacol Sin; 2013 Oct; 34(10):1310-6. PubMed ID: 23974518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine endotoxin-induced impairs pulmonary vascular function and right ventricular performance in infant rats and improvement with early vitamin D therapy.
    Mandell E; Powers KN; Harral JW; Seedorf GJ; Hunter KS; Abman SH; Dodson RB
    Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(12):L1438-46. PubMed ID: 26475735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho kinase mediates right ventricular systolic dysfunction in rats with chronic neonatal pulmonary hypertension.
    Gosal K; Dunlop K; Dhaliwal R; Ivanovska J; Kantores C; Desjardins JF; Connelly KA; McNamara PJ; Jain A; Jankov RP
    Am J Respir Cell Mol Biol; 2015 Jun; 52(6):717-27. PubMed ID: 25337652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simvastatin prevents and reverses chronic pulmonary hypertension in newborn rats via pleiotropic inhibition of RhoA signaling.
    Wong MJ; Kantores C; Ivanovska J; Jain A; Jankov RP
    Am J Physiol Lung Cell Mol Physiol; 2016 Nov; 311(5):L985-L999. PubMed ID: 27694473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genipin attenuates hyperoxia-induced lung injury and pulmonary hypertension via targeting glycogen synthase kinase-3 β in neonatal rats.
    Li J; Shi J; Li P; Guo X; Wang T; Liu A
    Nutrition; 2019 Jan; 57():237-244. PubMed ID: 30196116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2/3 phosphorylation.
    Bei Y; Hua-Huy T; Duong-Quy S; Nguyen VH; Chen W; Nicco C; Batteux F; Dinh-Xuan AT
    Pulm Pharmacol Ther; 2013 Dec; 26(6):635-43. PubMed ID: 23928001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of asymmetric dimethylarginine and Rho kinase in the vascular remodeling in monocrotaline-induced pulmonary hypertension.
    Li XH; Peng J; Tan N; Wu WH; Li TT; Shi RZ; Li YJ
    Vascul Pharmacol; 2010; 53(5-6):223-9. PubMed ID: 20840872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of EC-SOD worsens alveolar and vascular development in a neonatal mouse model of bleomycin-induced bronchopulmonary dysplasia and pulmonary hypertension.
    Delaney C; Wright RH; Tang JR; Woods C; Villegas L; Sherlock L; Savani RC; Abman SH; Nozik-Grayck E
    Pediatr Res; 2015 Dec; 78(6):634-40. PubMed ID: 26322414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.